OTCMKTS:NPHC - Nutra Pharma Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.0004 0.00 (0.00 %)
(As of 11/15/2018 01:25 PM ET)
Previous Close$0.0004
Today's Range$0.0003 - $0.0004
52-Week Range$0.0001 - $0.0069
Volume8.38 million shs
Average Volume25.11 million shs
Market Capitalization$1 million
P/E RatioN/A
Dividend YieldN/A
Beta6.12
Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States. The company offers Nyloxin and Nyloxin Extra Strength products, which are used as an oral spray for treating back pain, neck pain, headaches, joint pain, migraines, and neuralgia, as well as a topical gel for treating joint pain, neck pain, arthritis pain, and pain associated with repetitive stress; Pet Pain-Away, an over-the-counter pain reliever to treat pain in cats and dogs; Luxury Feet, an over-the-counter pain reliever to treat foot pain from high heels and stilettos; Nyloxin Military Strength for treating pain to the United States Military and Veteran's Administration; and Equine Nyloxin, a topical therapy for chronic pain in horses. It is also developing RPI-78M to treat neurological diseases and autoimmune diseases, including multiple sclerosis, adrenomyeloneuropathy, amyotrophic lateral sclerosis, rheumatoid arthritis, and myasthenia gravis; RPI-MN to treat viral diseases, including human immunodeficiency virus/AIDS and herpes; RPI-78 for pain and arthritis; and RPI-70 for pain. The company has a collaboration agreement with the International Security Group to develop nerve agent counter measures. Nutra Pharma Corp. was founded in 2000 and is based in Coral Springs, Florida.

Receive NPHC News and Ratings via Email

Sign-up to receive the latest news and ratings for NPHC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:NPHC
Previous Symbol
CUSIPN/A
Phone954-509-0911

Debt

Debt-to-Equity RatioN/A
Current Ratio0.10
Quick Ratio0.09

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$120,000.00
Price / Sales6.67
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-4,020,000.00
Net Margins-4,940.00%
Return on EquityN/A
Return on Assets-1,875.70%

Miscellaneous

Employees4
Outstanding Shares2,000,000,000
Market Cap$1 million
OptionableNot Optionable

Nutra Pharma (OTCMKTS:NPHC) Frequently Asked Questions

What is Nutra Pharma's stock symbol?

Nutra Pharma trades on the OTCMKTS under the ticker symbol "NPHC."

How were Nutra Pharma's earnings last quarter?

Nutra Pharma Corp. (OTCMKTS:NPHC) issued its quarterly earnings results on Friday, August, 17th. The company reported $0.00 EPS for the quarter. The business had revenue of $0.03 million for the quarter. View Nutra Pharma's Earnings History.

When is Nutra Pharma's next earnings date?

Nutra Pharma is scheduled to release their next quarterly earnings announcement on Monday, November 19th 2018. View Earnings Estimates for Nutra Pharma.

Has Nutra Pharma been receiving favorable news coverage?

Media headlines about NPHC stock have been trending very negative on Thursday, InfoTrie reports. The research firm scores the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Nutra Pharma earned a media sentiment score of -3.3 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the near future.

Who are some of Nutra Pharma's key competitors?

Who are Nutra Pharma's key executives?

Nutra Pharma's management team includes the folowing people:
  • Mr. Erik J. Deitsch, Chairman, CEO, Pres & CFO (Age 50)
  • Dr. Dale VanderPutten, Chief Scientific Officer (Age 59)
  • Mr. Neil Roth, Pres of Designer Diagnostics, Inc
  • Ms. Nina Goldstein, Sec. (Age 58)
  • Major General Kenneth Dowd, Strategic Advisor

How do I buy shares of Nutra Pharma?

Shares of NPHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Nutra Pharma's stock price today?

One share of NPHC stock can currently be purchased for approximately $0.0004.

How big of a company is Nutra Pharma?

Nutra Pharma has a market capitalization of $1 million and generates $120,000.00 in revenue each year. Nutra Pharma employs 4 workers across the globe.

What is Nutra Pharma's official website?

The official website for Nutra Pharma is http://www.nutrapharma.com.

How can I contact Nutra Pharma?

Nutra Pharma's mailing address is 12538 W. ATLANTIC BLVD., CORAL SPRINGS FL, 33071. The company can be reached via phone at 954-509-0911 or via email at [email protected]


MarketBeat Community Rating for Nutra Pharma (OTCMKTS NPHC)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  56 (Vote Outperform)
Underperform Votes:  38 (Vote Underperform)
Total Votes:  94
MarketBeat's community ratings are surveys of what our community members think about Nutra Pharma and other stocks. Vote "Outperform" if you believe NPHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NPHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/15/2018 by MarketBeat.com Staff

Featured Article: Stop Order

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel